Chicago Capital, LLC Amgen Inc Transaction History

Chicago Capital, LLC

$3.74 Billion
Q4 2024

A detailed history of Chicago Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Chicago Capital, LLC holds 14,380 shares of AMGN stock, worth $4.24 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

14,380

Previous 14,364 0.11%

Holding current value

$4.24 Million

Previous $4.63 Million 19.01%

% of portfolio

0.1%

Previous 0.13%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	BUY	$258.78 - $328.31 $4,140 - $5,252	16 Added 0.11%	14,380 $3.75 Million
Q3 2024 Oct 18, 2024	SELL	$309.38 - $337.38 $1.23 Million - $1.35 Million	-3,987 Reduced 21.73%	14,364 $4.63 Million
Q2 2024 Aug 06, 2024	SELL	$262.75 - $319.31 $148,979 - $181,048	-567 Reduced 3.0%	18,351 $5.73 Million
Q1 2024 Apr 15, 2024	BUY	$268.87 - $324.56 $82,811 - $99,964	308 Added 1.66%	18,918 $5.38 Million
Q4 2023 Jan 22, 2024	BUY	$255.7 - $288.46 $1.64 Million - $1.85 Million	6,407 Added 52.5%	18,610 $5.36 Million
Q1 2023 Apr 18, 2023	SELL	$225.79 - $275.2 $25,514 - $31,097	-113 Reduced 0.92%	12,203 $2.95 Million
Q3 2022 Oct 14, 2022	BUY	$224.46 - $253.15 $1,122 - $1,265	5 Added 0.04%	12,316 $2.78 Million
Q2 2022 Jul 21, 2022	BUY	$230.71 - $256.74 $57,677 - $64,185	250 Added 2.07%	12,311 $3 Million
Q1 2022 Apr 21, 2022	BUY	$219.27 - $242.57 $131,562 - $145,542	600 Added 5.24%	12,061 $2.92 Million
Q3 2021 Oct 28, 2021	SELL	$212.27 - $248.7 $63,681 - $74,610	-300 Reduced 2.55%	11,461 $2.44 Million
Q2 2021 Jul 22, 2021	SELL	$233.58 - $259.14 $135,476 - $150,301	-580 Reduced 4.7%	11,761 $2.87 Million
Q4 2020 Jan 25, 2021	BUY	$216.38 - $257.67 $6,491 - $7,730	30 Added 0.24%	12,341 $2.84 Million
Q2 2020 Jul 29, 2020	BUY	$197.81 - $242.74 $465,249 - $570,924	2,352 Added 23.62%	12,311 $2.9 Million
Q4 2019 Jan 14, 2020	SELL	$189.21 - $243.2 $13,244 - $17,024	-70 Reduced 0.7%	9,959 $2.4 Million
Q3 2019 Oct 29, 2019	BUY	$174.11 - $208.62 $29,598 - $35,465	170 Added 1.72%	10,029 $1.94 Million
Q2 2019 Jul 11, 2019	BUY	$166.7 - $195.41 $301,893 - $353,887	1,811 Added 22.5%	9,859 $1.82 Million
Q1 2019 Apr 23, 2019	SELL	$180.87 - $203.88 $382,359 - $431,002	-2,114 Reduced 20.8%	8,048 $1.53 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $51,379 - $59,976	-288 Reduced 2.76%	10,162 $1.98 Million
Q3 2018 Nov 02, 2018	SELL	$185.29 - $208.89 $83,380 - $94,000	-450 Reduced 4.13%	10,450 $2.17 Million
Q2 2018 Jul 19, 2018	BUY	$166.05 - $186.51 $449,497 - $504,882	2,707 Added 33.04%	10,900 $2.01 Million
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $1.39 Million - $1.62 Million	8,193 New	8,193 $1.4 Million

Others Institutions Holding AMGN

# of Institutions

3,118

Shares Held

410M

Call Options Held

8.54M

Put Options Held

7.02M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital, LLC with notifications on news.

Account

Chicago Capital, LLC Amgen Inc Transaction History